PHVS Pharvaris N.V.
Nasdaq · SEC CIK 1830487 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $32.63M 46 sales by 11 insiders
- Filings on record
- 52 since 2026-04-03, latest 2026-09-24 10:43
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Schikan Johannes Gerardus Christiaan Petrus | Dir | — | $9.65M |
| Lu Peng | Pres | — | $6.95M |
| Lesage Anne | Chief Early Development | — | $6.67M |
| Bjork Elisabeth | Dir | — | $2.28M |
| Abele Stefan Andreas | Chief Technical Ops Off | — | $2.03M |
| Glassman Robert | Dir | — | $1.49M |
| Souverijns Wim | Chief Commercial Off | — | $1.32M |
| Modig Berndt | CEO, Dir | — | $1.10M |
| Nassif David W. | CFO, CLO | — | $521.9K |
| Nijdam Anna | Principal Accounting Off | — | $307.5K |
| Monges Viviane | Dir | — | $292.9K |
Transactions 81
Purchase Sale Sale after option exercise All abbreviations
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-24 10:43 | 2026-09-22 | PHVS | Schikan Johannes Gerardus Christiaan Petrus | Dir | M - OptEx | $20.00 | +800 | 116.0K | +0.7% | +$16.0K |
| D | 2026-09-24 10:43 | 2026-09-22 | PHVS | Schikan Johannes Gerardus Christiaan Petrus | Dir | S - Sale+OE | $36.19 | -800 | 115.2K | -0.7% | -$29.0K |
| 2026-09-23 10:06 | 2026-09-21 | PHVS | Nassif David W. | CFO, CLO | S - Sale | $36.47 | -6,000 | 114.3K | -5% | -$218.8K | |
| 2026-09-23 10:06 | 2026-09-21 | PHVS | Nassif David W. | CFO, CLO | G - Gift | $0.00 | -500 | 113.8K | -0.4% | $0 | |
| D | 2026-09-21 16:20 | 2026-09-17 | PHVS | Lu Peng | Pres | M - OptEx | $2.59 | +100.0K | 165.0K | +154% | +$259.0K |
| D | 2026-09-21 16:20 | 2026-09-17 | PHVS | Lu Peng | Pres | S - Sale+OE | $35.00 | -100.0K | 65.0K | -61% | -$3.50M |
| 2026-09-21 16:18 | 2026-09-17 | PHVS | Schikan Johannes Gerardus Christiaan Petrus | Dir | S - Sale | $35.00 | -200.0K | 115.2K | -63% | -$7.00M | |
| DM | 2026-09-21 15:20 | 2026-09-17 | PHVS | Bjork Elisabeth | Dir | M - OptEx | $15.64 | +52.5K | 67.7K | +346% | +$821.1K |
| D | 2026-09-21 15:20 | 2026-09-17 | PHVS | Bjork Elisabeth | Dir | S - Sale+OE | $37.89 | -52.5K | 15.2K | -78% | -$1.99M |
| D | 2026-09-21 15:16 | 2026-09-17 | PHVS | Glassman Robert | Dir | M - OptEx | $18.14 | +14.5K | 25.0K | +138% | +$262.9K |
| D | 2026-09-21 15:16 | 2026-09-17 | PHVS | Glassman Robert | Dir | S - Sale+OE | $38.56 | -14.5K | 10.5K | -58% | -$558.8K |
| I | 2026-09-21 15:13 | 2026-09-17 | PHVS | Lesage Anne | Chief Early Development | S - Sale | $38.27 | -20.0K | 74.0K | -21% | -$765.5K |
| I | 2026-09-21 15:10 | 2026-09-17 | PHVS | Modig Berndt | CEO, Dir | M - OptEx | $35.00 | -300.0K | 650.0K | -32% | -$10.50M |
| D | 2026-09-17 13:22 | 2026-09-15 | PHVS | Abele Stefan Andreas | Chief Technical Ops Off | M - OptEx | $16.40 | +45.0K | 85.5K | +111% | +$738.0K |
| DM | 2026-09-17 13:22 | 2026-09-15 | PHVS | Abele Stefan Andreas | Chief Technical Ops Off | S - Sale+OE | $38.17 | -46.4K | 39.1K | -54% | -$1.77M |
| DT | 2026-09-17 09:18 | 2026-09-15 | PHVS | Glassman Robert | Dir | M - OptEx | $22.31 | +8,667 | 19.2K | +83% | +$193.4K |
| DT | 2026-09-17 09:18 | 2026-09-15 | PHVS | Glassman Robert | Dir | S - Sale+OE | $38.27 | -8,667 | 10.5K | -45% | -$331.7K |
| DT | 2026-09-16 14:07 | 2026-09-14 | PHVS | Souverijns Wim | Chief Commercial Off | M - OptEx | $17.43 | +20.0K | 65.1K | +44% | +$348.6K |
| DMT | 2026-09-16 14:07 | 2026-09-14+ | PHVS | Souverijns Wim | Chief Commercial Off | S - Sale+OE | $39.23 | -26.1K | 39.0K | -40% | -$1.02M |
| T | 2026-09-15 14:30 | 2026-09-11 | PHVS | Lu Peng | Pres | M - OptEx | $2.59 | +15.0K | 80.2K | +23% | +$38.9K |
| T | 2026-09-15 14:30 | 2026-09-11 | PHVS | Lu Peng | Pres | S - Sale+OE | $40.13 | -15.0K | 65.2K | -19% | -$601.9K |
| MT | 2026-09-15 14:30 | 2026-09-11+ | PHVS | Lu Peng | Pres | F - Tax | $37.77 | -226 | 65.0K | -0.3% | -$8,537 |
| T | 2026-09-15 14:15 | 2026-09-14 | PHVS | Modig Berndt | CEO, Dir | S - Sale | $39.40 | -2,291 | 128.3K | -2% | -$90.3K |
| DT | 2026-09-14 12:29 | 2026-09-10 | PHVS | Lesage Anne | Chief Early Development | M - OptEx | $8.05 | +30.0K | 86.5K | +53% | +$241.5K |
| DT | 2026-09-14 12:29 | 2026-09-10 | PHVS | Lesage Anne | Chief Early Development | S - Sale+OE | $38.30 | -30.0K | 56.5K | -35% | -$1.15M |
| DT | 2026-09-11 12:25 | 2026-09-09 | PHVS | Glassman Robert | Dir | M - OptEx | $20.00 | +8,000 | 18.5K | +76% | +$160.0K |
| DT | 2026-09-11 12:25 | 2026-09-09 | PHVS | Glassman Robert | Dir | S - Sale+OE | $37.55 | -8,000 | 10.5K | -43% | -$300.4K |
| T | 2026-09-09 11:19 | 2026-09-08 | PHVS | Lu Peng | Pres | M - OptEx | $2.59 | +15.0K | 80.2K | +23% | +$38.9K |
| T | 2026-09-09 11:19 | 2026-09-08 | PHVS | Lu Peng | Pres | S - Sale+OE | $40.68 | -15.0K | 65.2K | -19% | -$610.1K |
| T | 2026-08-18 11:49 | 2026-08-14 | PHVS | Modig Berndt | CEO, Dir | S - Sale | $34.77 | -2,292 | 130.6K | -2% | -$79.7K |
| M | 2026-08-13 16:35 | 2026-08-11+ | PHVS | Lu Peng | Pres | F - Tax | $34.62 | -226 | 65.2K | -0.3% | -$7,825 |
| T | 2026-07-15 13:08 | 2026-07-13 | PHVS | Modig Berndt | CEO, Dir | S - Sale | $34.97 | -2,292 | 132.9K | -2% | -$80.2K |
| M | 2026-07-14 15:46 | 2026-07-11+ | PHVS | Lu Peng | Chief Medical Off | F - Tax | $35.07 | -226 | 65.4K | -0.3% | -$7,926 |
| MT | 2026-07-01 19:06 | 2026-06-29+ | PHVS | Schikan Johannes Gerardus Christiaan Petrus | Dir | S - Sale | $35.41 | -37.6K | 315.2K | -11% | -$1.33M |
| DMT | 2026-07-01 19:02 | 2026-06-29+ | PHVS | Lesage Anne | Chief Early Development | M - OptEx | $6.85 | +38.5K | 86.6K | +80% | +$263.4K |
| DMT | 2026-07-01 19:02 | 2026-06-29+ | PHVS | Lesage Anne | Chief Early Development | S - Sale+OE | $35.37 | -38.5K | 58.8K | -40% | -$1.36M |
| DMTI | 2026-07-01 19:02 | 2026-06-29+ | PHVS | Lesage Anne | Chief Early Development | S - Sale+OE | $35.41 | -37.7K | 94.0K | -29% | -$1.33M |
| DMT | 2026-06-29 18:41 | 2026-06-25 | PHVS | Lesage Anne | Chief Early Development | M - OptEx | $4.73 | +2,300 | 58.8K | +4% | +$10.9K |
| DT | 2026-06-29 18:41 | 2026-06-25 | PHVS | Lesage Anne | Chief Early Development | S - Sale+OE | $35.12 | -2,300 | 56.5K | -4% | -$80.8K |
| DTI | 2026-06-29 18:41 | 2026-06-25 | PHVS | Lesage Anne | Chief Early Development | S - Sale+OE | $35.12 | -2,300 | 131.7K | -2% | -$80.8K |
| T | 2026-06-29 18:18 | 2026-06-29 | PHVS | Schikan Johannes Gerardus Christiaan Petrus | Dir | S - Sale | $35.10 | -2,400 | 352.8K | -0.7% | -$84.2K |
| DMT | 2026-06-29 18:18 | 2026-06-25+ | PHVS | Lu Peng | Chief Medical Off | M - OptEx | $2.59 | +29.7K | 80.3K | +59% | +$76.9K |
| DMT | 2026-06-29 18:18 | 2026-06-25+ | PHVS | Lu Peng | Chief Medical Off | S - Sale+OE | $34.30 | -29.7K | 65.6K | -31% | -$1.02M |
| DT | 2026-06-23 17:07 | 2026-06-18 | PHVS | Lu Peng | Chief Medical Off | M - OptEx | $2.59 | +300 | 65.9K | +0.5% | +$777 |
| DT | 2026-06-23 17:07 | 2026-06-18 | PHVS | Lu Peng | Chief Medical Off | S - Sale+OE | $34.00 | -300 | 65.6K | -0.5% | -$10.2K |
| MT | 2026-06-17 17:51 | 2026-06-15 | PHVS | Modig Berndt | CEO, Dir | S - Sale | $31.07 | -2,291 | 135.2K | -2% | -$71.2K |
| 2026-06-16 17:50 | 2026-06-12 | PHVS | Lu Peng | Chief Medical Off | F - Tax | $32.20 | -117 | 65.6K | -0.2% | -$3,767 | |
| 2026-06-15 17:22 | 2026-06-11 | PHVS | Lu Peng | Chief Medical Off | F - Tax | $31.51 | -109 | 65.7K | -0.2% | -$3,435 | |
| 2026-06-08 14:53 | 2026-06-04 | PHVS | Nijdam Anna | Principal Accounting Off | S - Sale | $30.87 | -2,670 | 46.3K | -5% | -$82.4K | |
| 2026-05-26 17:53 | 2026-05-21 | PHVS | Monges Viviane | Dir | S - Sale | $30.29 | -9,667 | 5,500 | -64% | -$292.9K | |
| DM | 2026-05-26 17:45 | 2026-05-21+ | PHVS | Nijdam Anna | Principal Accounting Off | M - OptEx | $20.00 | +7,330 | 54.4K | +16% | +$146.6K |
| DM | 2026-05-26 17:45 | 2026-05-21+ | PHVS | Nijdam Anna | Principal Accounting Off | S - Sale+OE | $30.70 | -7,330 | 48.9K | -13% | -$225.1K |
| 2026-05-26 17:42 | 2026-05-21 | PHVS | Nassif David W. | CFO, CLO | S - Sale | $30.31 | -10.0K | 120.3K | -8% | -$303.1K | |
| DT | 2026-05-22 14:54 | 2026-05-20 | PHVS | Bjork Elisabeth | Dir | M - OptEx | $8.05 | +10.0K | 25.2K | +66% | +$80.5K |
| DT | 2026-05-22 14:54 | 2026-05-20 | PHVS | Bjork Elisabeth | Dir | S - Sale+OE | $29.32 | -10.0K | 15.2K | -40% | -$293.2K |
| T | 2026-05-20 17:33 | 2026-05-18 | PHVS | Modig Berndt | CEO, Dir | S - Sale | $29.22 | -2,292 | 137.5K | -2% | -$67.0K |
| D | 2026-05-19 18:48 | 2026-05-15 | PHVS | Glassman Robert | Dir | M - OptEx | $22.31 | +5,333 | 20.5K | +35% | +$119.0K |
| DM | 2026-05-19 18:48 | 2026-05-15 | PHVS | Glassman Robert | Dir | S - Sale+OE | $29.82 | -10.0K | 10.5K | -49% | -$298.2K |
| 2026-05-19 18:44 | 2026-05-15 | PHVS | Abele Stefan Andreas | Chief Technical Ops Off | S - Sale | $29.82 | -8,748 | 35.2K | -20% | -$260.9K | |
| T | 2026-05-19 18:42 | 2026-05-15 | PHVS | Souverijns Wim | Chief Commercial Off | S - Sale | $29.92 | -10.0K | 45.1K | -18% | -$299.2K |
| M | 2026-05-13 18:48 | 2026-05-11+ | PHVS | Lu Peng | Chief Medical Off | F - Tax | $30.02 | -226 | 65.9K | -0.3% | -$6,784 |
| DT | 2026-05-05 15:51 | 2026-05-01 | PHVS | Lu Peng | Chief Medical Off | M - OptEx | $2.59 | +14.2K | 80.2K | +21% | +$36.7K |
| DMT | 2026-05-05 15:51 | 2026-05-01 | PHVS | Lu Peng | Chief Medical Off | S - Sale+OE | $30.17 | -14.2K | 66.1K | -18% | -$427.4K |
| MT | 2026-05-01 19:32 | 2026-04-29+ | PHVS | Schikan Johannes Gerardus Christiaan Petrus | Dir | S - Sale | $30.29 | -32.9K | 355.2K | -8% | -$996.5K |
| DMT | 2026-05-01 19:30 | 2026-04-29+ | PHVS | Lesage Anne | Chief Early Development | M - OptEx | $6.46 | +25.4K | 74.5K | +52% | +$164.1K |
| DMT | 2026-05-01 19:30 | 2026-04-29+ | PHVS | Lesage Anne | Chief Early Development | S - Sale+OE | $30.23 | -25.4K | 56.5K | -31% | -$767.8K |
| DMTI | 2026-05-01 19:30 | 2026-04-29+ | PHVS | Lesage Anne | Chief Early Development | S - Sale+OE | $30.22 | -22.9K | 134.0K | -15% | -$692.1K |
| DMT | 2026-05-01 19:09 | 2026-04-29+ | PHVS | Lu Peng | Chief Medical Off | M - OptEx | $2.59 | +18.7K | 81.1K | +30% | +$48.5K |
| DMT | 2026-05-01 19:09 | 2026-04-29+ | PHVS | Lu Peng | Chief Medical Off | S - Sale+OE | $30.21 | -18.7K | 66.1K | -22% | -$565.9K |
| MT | 2026-04-24 14:09 | 2026-04-22+ | PHVS | Schikan Johannes Gerardus Christiaan Petrus | Dir | S - Sale | $30.05 | -7,100 | 388.1K | -2% | -$213.4K |
| DMT | 2026-04-24 12:18 | 2026-04-22+ | PHVS | Lesage Anne | Chief Early Development | M - OptEx | $7.62 | +7,600 | 56.5K | +16% | +$57.9K |
| DMT | 2026-04-24 12:18 | 2026-04-22+ | PHVS | Lesage Anne | Chief Early Development | S - Sale+OE | $30.05 | -7,600 | 56.5K | -12% | -$228.4K |
| DMTI | 2026-04-24 12:18 | 2026-04-22+ | PHVS | Lesage Anne | Chief Early Development | S - Sale+OE | $30.05 | -7,100 | 156.9K | -4% | -$213.4K |
| DMT | 2026-04-24 11:27 | 2026-04-22+ | PHVS | Lu Peng | Chief Medical Off | M - OptEx | $2.59 | +7,101 | 66.2K | +12% | +$18.4K |
| DMT | 2026-04-24 11:27 | 2026-04-22+ | PHVS | Lu Peng | Chief Medical Off | S - Sale+OE | $30.05 | -7,101 | 66.1K | -10% | -$213.4K |
| 2026-04-20 17:38 | 2026-04-16 | PHVS | Lu Peng | Chief Medical Off | F - Tax | $28.78 | -226 | 66.1K | -0.3% | -$6,504 | |
| T | 2026-04-20 15:00 | 2026-04-16 | PHVS | Modig Berndt | CEO, Dir | S - Sale | $28.60 | -2,292 | 139.8K | -2% | -$65.6K |
| 2026-04-14 17:52 | 2026-04-11 | PHVS | Nijdam Anna | Principal Accounting Off | F - Tax | $26.63 | -548 | 48.9K | -1% | -$14.6K | |
| MT | 2026-04-10 13:42 | 2026-04-09 | PHVS | Modig Berndt | CEO, Dir | S - Sale | $27.74 | -23.3K | 142.1K | -14% | -$647.3K |
| 2026-04-08 15:00 | 2026-04-06 | PHVS | Nijdam Anna | Principal Accounting Off | F - Tax | $28.56 | -1,167 | 49.5K | -2% | -$33.3K | |
| 2026-04-03 14:07 | 2026-04-01 | PHVS | Nijdam Anna | Principal Accounting Off | F - Tax | $28.25 | -1,164 | 50.7K | -2% | -$32.9K |